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ProteaseIn light induced retinal degeneration (LIRD) photoreceptor cell death is mediated by caspase independent
mechanisms. The activation of LEI/L-DNase II pathway in this model, is due to cathepsin D release from lyso-
somes, although the underlying mechanism remains poorly understood. In this paper we studied the involve-
ment of calpains in lysosomal permeabilization. We investigated, for the ﬁrst time, the calpain targets at
lysosomal membrane level. We found that calpain 1 is responsible for lysosomal permeabilization by cleav-
age of the lysosomal associated membrane protein 2 (LAMP 2). Moreover, LAMP 2 degradation and lysosomal
permeabilization were rescued by calpain inhibition and the use of MEF−/− lamp 2 cells indicates that the
cleavage of LAMP 2A is essential for this permeabilization. Finally, we found that LAMP 2 is cleaved in
LIRD, suggesting that the mechanism of calpain induced lysosomal permeabilization is not exclusive of a sin-
gle cell death model. Overall, these data shed new light on understanding the mechanisms of lysosomal and
caspase-independent cell death and point to the original targets for development of the new therapeutic
protocols.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Neuron cell death is central to all degenerative diseases. For exam-
ple, the Alzheimer disease, described in 1906, is characterized by cho-
linergic neuron death while in Parkinson and Huntington's disease
dopaminergic neurons undergo cell death [1]. Neurodegeneration
also occurs in the retina as, for example, in retinitis pigmentosa or
in age-related macular degeneration, where photoreceptors degen-
erate due to cell death [2].
According to morphological criteria, Clarke described in 1990 three
types of cell death. This nomenclature was updated in 2007 and 2012
by the NCCD [3,4].
Type I programmed cell death, or apoptosis, is characterized by
rounding-up of the cell, retraction of pseudopodia and cellular volume,
chromatin condensation, and nuclear fragmentation. There is little or no, N-Acetyl-Leu-Leu-Nle-CHO;
, Bovine Serum Albumin; CAD,
haperon mediated autophagy;
xynonenal; LAMP 2, Lysosomal
LDH, Lactate dehydrogenase;
Inhibitor; LIRD, Light Induced
MTT, Thiazolil Blue Tetrazolium
PBS, Phosphate-Buffered Saline;
Western Blot
e de Recherches des Cordeliers,
1 83.
a).
l rights reserved.ultrastructural modiﬁcation of cytoplasmic organelles, plasma mem-
brane blebbing and maintenance of an intact plasma membrane until
late stages of the process.
Type II or autophagic cell death occurs without chromatin conden-
sation and is accompanied by massive autophagic vacuolization (LC3
positive vacuoles) of the cytoplasm.
Type III or necrosis shows cytoplasmic swelling, mechanical rupture
of the plasma membrane, dilation of cytoplasmic organelles, as well as
moderate chromatin condensation.
Many other types of cell death have been described during the last
years, so that the NCCD in 2012 enlarged the classiﬁcation to 13 dif-
ferent types of cell death according to biochemical features [4].
Of these different types of cell death, apoptosis is largely involved in
the degenerative diseases of the central nervous system. Its molecular
pathways have been studied for several years. Nevertheless, these studies
have been concentrated on the role of caspases in apoptotic demise. How-
ever,many studies have shown the induction of caspase-independent cell
death mechanisms involving other proteases as apoptotic effectors like
calpains or cathepsins.
For example, studies of Momoni and Kanje [5,6] show that adult spi-
nal cord slices from mice exhibited apoptotic features in motor neurons
after excision and that leupeptin, calpain inhibitor XI and calpain inhibi-
tor VI, but not Z-VAD.fmk, inhibit apoptosis of these neurons. Another
study [7] shows that cortical neurons treated with 250 μM HOCl
exhibited several biochemical markers of apoptosis in the absence
of caspase activation. In contrast, calpain inhibitors protect cortical
2245G.E. Villalpando Rodriguez, A. Torriglia / Biochimica et Biophysica Acta 1833 (2013) 2244–2253neurons from apoptosis. Moreover, this study reported that calpain
activation induces lysosomal disruption and that stabilization of ly-
sosomes and inhibition of cathepsins protect cells from cell death.
Although the studies of Momoni and Kanje [5,6], Yap [7] and
others have shown the implication of calpains in cell death, little is
known about the precise molecular mechanisms of calpain mediated
cell death.
In 1998, Yamashima proposed the “calpain–cathepsin hypothesis”
[8] which suggests that lysosomal membrane of post-ischemic Cornu
Ammonis (CA) 1 neurons is disrupted by activation of calpain 1
(μ-calpain) which causes the release of lysosomal proteases, in par-
ticular cathepsin B. This release causes post-ischemic CA 1 neuronal
death in primates which is prevented with CA-074, a speciﬁc inhib-
itor of cathepsin B. This hypothesis has been used by other authors,
as Ceccariglia in 2010 [9] to explain the effects of a calpain inhibitor
on cathepsin D activation in CA 3 hippocampal neurons. Tsukada also
used this hypothesis to explain the release of lysosomal DNase II in
ischemic neuronal necrosis and its role on cell death [10]. This hy-
pothesis has been also cited in the 2004 review of Syntichaki and
Tavernarakis as part of the machinery of necrosis [11]. Yamashima
built his hypothesis on the observation that calpain 1 is activated in ly-
sosomal membrane of CA 1 neurons 20 min after ischemia [12]. Until
2010 this hypothesis has been accepted without knowing the mecha-
nism by which calpain 1 destabilizes lysosomal membrane. Recently,
Sahara and Yamashima found that activated calpain 1 colocalizes with
the heat shock protein 70.1 (Hsp70.1) at the lysosomal membrane of
the post-ischemic CA 1 neurons after the ischemia–reperfusion in-
sult. They also reported that in CA 1 neurons Hsp 70.1 is cleaved, in
vitro, in the presence of calpain 1, a cleavage that is inhibited with
N-Acetyl-Leu-Leu-Nle-CHO (ALLN) and is more important in presence
of Hydroxynonenal (HNE) or H2O2 [13].
In another model such as Light Induced Retinal Degeneration
(LIRD), we found that photoreceptors of Fisher rats exposed to con-
tinuous light undergo caspase-independent cell death with an activa-
tion of LEI/L-DNase II. Two proteases were found activated: calpains
and cathepsin D. We previously showed that cathepsin D, but not
calpains [14], is responsible for the cleavage of LEI into L-DNase II. In-
hibition of this protease protects the photoreceptors from cell death
[15]. However, the precise molecular mechanism behind the calpains
involvement in this model is still unknown. Yamashima found in his
ischemia–reperfusion model, an activation of calpain 1 and a release
of cathepsin B from lysosomes. He also showed that inhibition of calpain
was neuroprotective. In agreement, we found that inhibition of cathep-
sin D, in our LIRD model, is also protective. In this work we further
tested the Yamashima's hypothesis which proposes that, calpain 1 is
responsible for lysosomal permeabilization. We thus investigated the
calpain's targets at the lysosomal membrane during permeabilization
by using a cellular model presenting lysosomal permeabilization and
L-DNase II activation, such as treatment of HeLa cells with ciproﬂoxacin.2. Materials and methods
2.1. Cell lines and culture conditions
HeLa cells (S3 clone) were cultured in DMEM (Dulbecco’s Modi-
ﬁed Eagle Medium) with GlutaMAX™ I, supplemented with 4.5 g/L
(25 mM) D-glucose, 0.11 g/L (1 mM) sodium pyruvate, 10% fetal bo-
vine serum, 0.5% penicillin/streptomycin at 37 °C under 5% CO2 and
90% of relative humidity.
Wild type Mouse Embryonic Fibroblasts (MEF) and MEF Lamp 2−/−
cells (a generous gift from Dr. Alex Schneede) were cultured in DMEM
(Dulbecco's modiﬁed eagle medium) supplemented with 4.5 g/L
(25 mM) D-glucose, 0.58 g/L (3.97 mM) L-glutamine 10% fetal bo-
vine serum and 0.5% penicillin/streptomycin at 37 °C under 5% CO2
and 90% of relative humidity.2.2. Cell death induction and proteases inhibition
For cell death induction different concentrations of ciproﬂoxacin
(Santa Cruz) were used to evaluate the appropriated dose.
Calpains were inhibited by using Calpain VI inhibitor (Calbiochem
ref. 208745) prepared in DMSO at a concentration of 78 nM.
Cathepsin D was inhibited with Pepstatin A-BODIPY® (Invitrogen)
100 nM alone or in combination with calpain inhibitor VI.
2.3. MTT reduction assay
1 × 105 HeLa cells were seeded in 24-wells plate. After 48 h, cells
were treated with ciproﬂoxacin with or without inhibitors, alone or in
combination as mentioned before. Thiazolil Blue Tetrazolium Bromide
(MTT) (Sigma-Aldrich) was diluted in phosphate-buffered saline (PBS)
solution at a concentration of 1 mg/mL. Twenty-four hours after treat-
ment, culture medium was removed and 250 μL of MTT was added to
each well. The plate was kept for 1 h at 37 °C. Cells were then lysed
with 250 μL of isopropanol. MTT reduction in each sample was subse-
quently assessed by measuring absorption at 570 nm versus 630 nm
using a microplate reader (BioRad). The survival rate was expressed as
the percentage of the untreated cells.
2.4. Cytotoxicity assay
1 × 105 HeLa cells were seeded in 24-wells plate and treated as
mentioned above, and the cytotoxicity was measured 24 h after the
treatment by measuring lactate dehydrogenase (LDH) activity using
a LDH kit (Roche). Medium of each condition was incubated with
100 μL LDH reaction mixture for 30 min at room temperature. Cells
treated with 0.2% Triton X-100 constituted positive control representing
100% of cytotoxicity. Each samplewas subsequently assessed bymeasur-
ing absorption at 490 nm versus 630 nm using a microplate reader
(BioRad).
2.5. Clonogenic test
HeLa cells were seeded in 1 mL of complete medium at the density
of 6 × 104 cells/well in 24-well plate and treated 24 h later with
350 μg/mL ciproﬂoxacin alone or in combination with 78 nM calpain
inhibitor VI. At the end of the treatment cells were washed with PBS
and trypsinized. For each condition, 104 cells were seeded into 6-well
plate and grown with complete medium. Ten days later, medium was
removed and cells were carefully washed with PBS, ﬁxed and stained
with 2 mL of 6% glutaraldehyde and 5% cresyl violet. After 30 min,
staining solution was removed; plates were washed with tap water,
and dried in normal air at room temperature. The surface of the plate
occupied by the colonies was calculated as follows: pictures of each
platewere taken in constant conditions of distance between the camera
and the plate, source of light, ISO, zoom, exposition time and aperture of
diaphragm. The area of analysis for the wells on the plate was selected
(the radius was the same for all the wells). Using image analysis soft-
ware, every image was binarized and the rate between the area occu-
pied by colonies and the total area of the well was calculated.
2.6. Terminal transferase dUTP nick end labeling (TUNEL)
1 × 105 HeLa cells/mL were seeded in wells of lab-tek lips (Nunc).
After 48 h they were treated with 350 μg/mL of ciproﬂoxacin and
24 h after treatment they were air dried and ﬁxed in 4% paraformal-
dehyde 15 min at room temperature and then washed twice with
PBS. The cells were then permeabilized with 0.1% Triton X-100 in
0.1% sodium citrate for 2 min at 4 °C. After washing once with PBS,
half of the sections were incubated for 30 min with calf intestinal al-
kaline phosphatase 6.66 U/well (Invitrogen) at 37 °C. After phospha-
tase incubation sections were rinsed once with PBS and incubated 1 h
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ture at 37 °C in dark chamber. The other half was incubated directly
with the TUNEL reaction mixture. Cells were then rinsed tree times
with PBS and incubated with DAPI 1/5000. Finally three washes
with PBS and three washes with distillated water were performed
and cells were covered with 50% glycerol in PBS and mounted with
coverslips. For positive control section were incubated 15 min with
DNase I (Sigma) 60 UI/mL at room temperature before incubation
with TUNEL reaction mixture. For negative control sections were in-
cubated with TUNEL label solution (without terminal transferase) in-
stead of TUNEL reaction mixture.
2.7. Nuclear/cytoplasmic fractions
5 × 105 HeLa cells were seeded in a 25 cm2 Falcon bottle.
Forty-eight hours after seeding cells were treated with 350 μg/mL
of ciproﬂoxacin. Twenty-four hours after treatment, cells (attached
and ﬂoating) were collected by scrapping and washed 2 times in cold
PBS (every time at 370 ×g, 5 min at 4 °C) and resuspended in an
ice-cold hypo-osmotic solution of 1.5 mM MgCl2. After mechanical dis-
ruption of cell membranes by using a tight-ﬁtting Dounce B potter
(10–15 strokes), they were centrifuged and the cytoplasmic fractions
contained in the supernatants were collected. The pellets were washed
2 times with the MgCl2 solution and resuspended in 10 μL of 50 mM
Tris, 50 mM MgCl2 and 50 mM CaCl2 pH 7.4 and incubated with
20 UI/mL of DNase I at room temperature for 10 min. Finally Laemmli
buffer was added to 60,000 nucleus per sample forWestern Blot analy-
sis. For the cytoplasmic fractions, protein measurement was performed
with bicinchoninic acid (BCA)™ Protein Assay Kit (Thermo Scientiﬁc)
using bovine serum albumin (BSA) as standard and Laemmli buffer
was added for Western Blot analysis.
2.8. Cell transfection
2 × 106 MEF Lamp 2−/− cells at 60% conﬂuence were transfected by
electroporation (amaxa Nucleofector™ II and BTX BTXpress™ transfec-
tion solution) with 5 μg of hLamp 2A plasmid (a generous gift from
Dr. Alex Schneede). Twenty-four hours after transfection cells were
treated with 350 μg/mL of ciproﬂoxacin alone or in combination with
calpain VI inhibitor 78 nM.
2.9. Lysosomes puriﬁcation
2.9.1. From rat brain
Lewis rats were deeply anesthetized with sodium pentobarbital
25 mg/kg (CEVA) and extensively perfused through an intracardiac
catheter with a saline solution to eliminate blood. Brain was then re-
moved and homogenized with a Potter-Elvehjem teﬂon tissue grinder
by 20 strokes with 10 mM Tris–HCl, 1 mM EDTA, and 250 mM sucrose
pH 7.4 10%w/vol. After 10 min of 600 ×g centrifugation, at 4 °C, super-
natant was recovered and centrifuged at 100,000 ×g, 1 h at 4 °C. The
cytosolic fraction (supernatant) was separated from microsome frac-
tion (pellet) which was washed by re-suspension with the same solu-
tion for homogenization and re-centrifuged at 100,000 ×g, 1 h at 4 °C.
Pellet was re-suspended in cold PBS and protein measurement was
performed with BCA™ Protein Assay Kit (Thermo Scientiﬁc) using BSA
as standard.
2.9.2. From HeLa cells
Two 75 cm2 falcon of conﬂuent HeLa cells (control and treated
with ciproﬂoxacin alone or in combination with calpain inhibitor VI)
were washed (with PBS), harvested (with cell scraper), pelleted at
370 ×g 5 min and re-suspended with 300 μL of 10 mM HEPES, 2 mM
MgCl2, 1 mM DTT, 150 mM sucrose, 1 mM EGTA and 0.1% BSA, pH 7.5
and incubated 5 min at 0 °C. Mechanical disruption of cell membranes
was performed using a tight-ﬁtting Dounce B potter (10–15 strokes).Three hundred microliters of 10 mM HEPES, 2 mM MgCl2, 1 mM DTT,
350 mM sucrose, 1 mM EGTA and 0.1% BSA, pH 7.5 were added and
the ﬁnal volume was adjusted to 2 mL with 10 mM HEPES, 2 mM
MgCl2, 1 mM DTT, 250 mM sucrose and 1 mM EGTA, 0.1%BSA, pH 7.5.
The lysate is layered on the top of a continuous linear sucrose gradi-
entmadewith a gradient formerwith a 12.56% sucrose and 84% sucrose
solutions containing 10 mM HEPES, 2 mMMgCl2, 1 mM DTT, 250 mM
sucrose, 1 mM EGTA and 0.1% BSA, pH 7.5. Organelles were separated
by centrifugation at 170,000 ×g, 2 h at 4 °C in SW41 Beckman rotor
using a Kontron utracentrifuge. A 2 mL fraction is harvested from the
top of the gradient, which contains the lysosomes, and was diluted 2
times with 10 mM HEPES, 2 mM MgCl2, 1 mM DTT, 250 mM sucrose,
1 mM EGTA and 0.1% BSA, pH 7.5 and centrifuged at 16,000 ×g, 4 °C
for 10 min.
2.10. Lysosomal in vitro permeabilization
Microsomes (2 mg/mL) puriﬁed from rat brain were diluted with
100 mM Imidazol 1 mM 2-mercaptoethanol, 5 mM L-cystein and
10 mM CaCl2 4% DMSO pH 7.3 and incubated at 37 °C for 3 h with
27.5 μg/mL calpain I or 27.5 μg/mL calpain II (Calbiochem®). For con-
trol experiments, microsomes were incubated with 10 μM calpastatine
(Calbiochem®) at 37 °C for 3 h in the same buffer for calpains and an-
other controlwas used by dilution ofmicrosomeswith 20 mM imidazole,
5 mM 2-mercaptoethanol, 1 mM EDTA, 1 mM EGTA and 30% glycerol
pH 6.8 and incubated at 37 °C for 3 h.
After incubation, microsomes were centrifuged 100,000 ×g, 1 h at
4 °C and soluble fractions were separated from microsomal fractions
and solubilized with Laemmli sample buffer forWestern Blot analysis.
2.11. Lysosomal membrane protein puriﬁcation
After lysosomal puriﬁcation, the pellet was re-suspended with
1.5 mM MgCl2 and incubated for 20 min on ice. Membrane proteins
were recovered by centrifugation at 16,000 ×g, 1 h at 4 °C.
2.12. Western Blot
After dilution of samples with Laemmli buffer, proteins were de-
natured by heating 2 min at 95 °C. Extracted proteins were separated
by 7.5% (for LAMP 2 polyclonal), 10% (LAMP 2 monoclonal, Actin), or
12% (LAMP 1, Cathepsin D, LEI/L-DNase II, Actin, Lamin) SDS-PAGE,
immobilized on nitrocellulose membrane (PROTAN®, Whatman®)
and blotted with: anti-LAMP 1, anti-Cathepsin D and anti-Cathepsin D
(Oncogene) at 1/1000 dilution and anti-LAMP 2 polyclonal (Sigma),
anti-LAMP 2 clone ABL-93 (MILLIPORE), anti-LEI/L-DNase II (produced
in our laboratory) and anti-Actin, anti-Lamin B (Santa Cruz), at 1/1000
dilution, anti-HSP 70 (BD Bioscience) at 1/3000 dilution. The secondary
antibodies conjugated to HRP (Vector) were used in a 1/5000 dilution.
Finally SuperSignal® West Pico Chemiluminescent Substrate (Thermo
Scientiﬁc) was used to reveal the signal.
2.13. Immunocytochemistry
1 × 105 HeLa cells/mL or 6 × 104 MEF cells/mL were seeded in
coverslips inside 24-wells plates. Forty-eight hours after seeding they
were treated with 350 μg/mL of ciproﬂoxacin with or without calpain
inhibitor. Twenty-four hours after treatment they were washed twice
with PBS containing Ca2+ and Mg2+, ﬁxed in 4% paraformaldehyde
for 15 min at room temperature (all steps were performed at room
temperature) and then washed twice with PBS. Permeabilization was
performed with 0.3%Triton X-100 for 15 min. The cells were then
washed twice with PBS and non-speciﬁc protein binding sites were
blocked by 1 h incubation in a blocking buffer containing 1% non fat
milk in PBS. Cells were further incubated with anti-Cathepsin D 1/500
for HeLa cells and 1/100 for MEF cells, anti-LAMP 2 monoclonal,
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1 h. This was followed by two washes with PBS and incubation for 1 h
with a 1:500 dilution of anti-rabbit Alexa Fluor® 546 conjugated anti-
body, or anti-goat Alexa Fluor® 488 conjugated antibody (Invitrogen).
Cells were ﬁnally washed twice with PBS, incubated for 1 min with 4-6
di-aminidino-2-henyl indoledichloride DAPI 1/5000 (Sigma-Aldrich)
and washed tree times with PBS and tree times with bidistilled water.
Cells were covered with 50% glycerol in PBS and mounted on slips. Im-
munoreactivity was visualized using ﬂuorescence microscopy with an
Olympus microscope BX51, or a Zeiss LSM 710 confocal microscope.
2.14. Lysosensor staining
1 × 105 HeLa cells/mL were seeded in coverslips inside 24-wells
plate. The fourth day of the culture, they were treated with 350 μg/mL
of ciproﬂoxacin with or without calpain inhibitor VI. Twenty-four
hours after treatment they were incubated at 37 °C 5% CO2 with 1 μM
LysoSensor Green DND-153 (Molecular Probes), after 1 h they were
washed once, covered with PBS and mounted on slips. The signal was
immediately visualized using ﬂuorescence microscopy with a Zeiss
LSM 710 confocal microscope.
2.15. Retinal light damage in rats
Six to eight-week-old Fischer male rats were exposed to a con-
stant light for 5 and 7 days, at an illumination level of 1000 lx provid-
ed by two 20 W white ﬂuorescent bulbs suspended 20 cm above the
bottom of transparent polycarbonate cages. The rats were killed using
carbon dioxide. Enucleation of the eyes was carried out immediately
after killing. Neuroretina was dissected and frozen immediately at
−20 °C.
2.16. Protein extraction from illuminated retina
After defrosting, the retinas were homogenized in 20% weight–
volume ofM-Per buffer (Thermo Scientiﬁc), using a Potter homogenizer.
The homogenate was then incubated on ice for 15 min and centrifuged
(15,000 ×g, 4 °C) for 15 min. Supernatant (60 μg) was recovered for
Western Blot analysis.
3. Results
3.1. Calpain I mediates lysosomal permeabilization in vitro
Since our in vivo model shows an activation of two proteases,
calpains and cathepsin D, and it was observed that cathepsin D was
responsible for LEI cleavage,wewere interested in exploring the hypoth-
esis according to which calpains may be involved in lysosomal perme-
abilization. We therefore performed the subcellular fractions enriched
with lysosomes from rat brain. The lysosomes were next incubated
with or without calpain 1 or calpain 2. After digestion, calpain 1 solubleFig. 1. Lysosomes release cathepsin D in the presence of calpain 1. Cathepsin D is released fro
two controls were used: lysosomes without exogenous calpain (Ctl), and lysosomes with c
pernatant (soluble fraction) from lysosomes digested with calpain 1 or calpain 2. Cathepsin
(Ctl, Inh) (left panel). The same amounts of cathepsin D were observed in lysosomes digested
as protein loading control for the amount of microsomes used. These are representative imfractions revealed an increased release of cathepsin D from lysosomes,
as compared to the control or to the same sample incubatedwith calpain
and its inhibitor. In contrast, the same was performed with calpain 2
which did not show any difference between control and digested lyso-
somes (Fig. 1). Similar results were obtained when using lysosomes pre-
pared fromHeLa cells (data not shown). These experiments pointed to a
speciﬁc and selective involvement of calpain 1 in cathepsin D release
from lysosomes.3.2. Ciproﬂoxacin treated HeLa cells, a cellular model that approaches to
LIRD events
Because recombinant calpain 1 permeabilized puriﬁed lysosomes,
we looked for a cellular model of lysosomal permeabilization activat-
ing the cell death pathways seen in LIRD. We selected as a model the
treatment of HeLa cells with the ciproﬂoxacin antibiotic which trig-
gers this apoptosis paradigm [16].
Lysosomal permeabilization in HeLa cells treated with 350 μg/mL
of ciproﬂoxacin was ﬁrst evaluated at 24 h of treatment by labeling
cathepsin D. Control cells showed a punctated staining indicating ly-
sosomal localization of this protease (Fig. 2 upper panel). In contrast,
treated cells presented a diffuse staining. This diffuse staining was
only found in apoptotic cells suggesting that the release of cathepsin D
into the cytoplasm occurs in an advanced stage of cell death. To evaluate
the implication of calpain 1 in this permeabilization, cells were treated
with ciproﬂoxacin in the presence of calpain inhibitor VI. In this condition
cells recovered their punctated staining which suggested a protection of
the lysosomalmembrane (Fig. 2 upper panel), supporting the hypothesis
that calpain 1 could be involved in lysosomal permeabilization.
To further support these results lysosomes were labeled with
LysoSensor, a lysosome tracer that accumulates in lysosomes and changes
its emission wavelength with the pH. This was done by assuming that
permeabilized lysosomes, which were not able to retain cathepsin D
were not able to maintain the H+ gradient, either. In addition, as
this tracer accumulates in lysosomes it allowed us to ascertain that
lysosomes were permeabilized, not disrupted. The assessment of
the change in LysoSensor emission by a spectral analysis shows a false
color image of the cells at 615 nm (Fig. 2 lower panel). We found that
the treatment with ciproﬂoxacin highly increased the emission of lyso-
somes at this wavelength indicating an increase of pH when compared
with control cells. It is interesting to note that the addition of calpain in-
hibitor VI to the ciproﬂoxacin treated cells reversed this process, further
supporting the hypothesis that calpain is involved in lysosomal mem-
brane permeabilization.
Because in LIRD lysosomes permeabilization is also associated with
cell death via activation of LEI/L-DNase II pathway, we investigated
the cell death effectors in ciproﬂoxacin treated cells.
First, we studied effects of ciproﬂoxacin treatment on cell survival. As
Boya and collaborators have shown, ciproﬂoxacin induces cell death [16].
We studied the effects of different ciproﬂoxacin concentrations (from 50
up to 500 μg/mL during 24 h) by testingMTT reduction and LDH release.m digested lysosomes (microsomes), by calpain 1 and calpain 2. For each Western Blot
alpain inhibitor calpastatin (Inh). The presence of cathepsin D was detected in the su-
D release is more important in lysosomes digested with calpain 1 (C) than the controls
with calpain 2 (C), as in both type of controls (Ctl, Inh) (right panel). LAMP 1 was used
ages of three independent experiments.
Fig. 2. Calpain 1 participates to lysosomal permeabilization. Upper panel: lysosomal permeabilization was detected by immunostaining of cathepsin D (red), nucleus are stained
with DAPI (blue). Control cells showed a punctate staining while in cells treated with ciproﬂoxacin (24 h) the staining was diffuse. Cells treated with ciproﬂoxacin in combination
with calpain VI inhibitor (24 h) recovered their punctate staining. Lower panel: LysoSensor staining showed a change of pH inside lysosomes treated with ciproﬂoxacin, which is
restored by calpain inhibitor VI. Pictures obtained at an emission of 615 nm are shown. The intensity of labeling is shown in false color (min/max, acidic to basic, blue to red scale).
Scale bar represents 25 μm.
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and that no signiﬁcant LDH release was detectable (supplementary
Fig. 1B).We also veriﬁed for activation of autophagyby immunodetection
of LC3 and could not detect any labeling (data not shown) l.
We next investigated cell death pathways activated in ciproﬂoxa-
cin treated cells. Since caspase dependent apoptosis culminates with
the activation of caspase 3 or 7 which in turn activates caspase acti-
vated DNase (CAD) that cleaves DNA and generates 3′OH ends, we
veriﬁed if this DNase was activated during ciproﬂoxacin treatment.
Classical TUNEL assay shows the absence of 3′OH ends (Fig. 3A),
that suggested the absence of CAD activity. Moreover, as type II DNases
generate 3′P endswe added a phosphatase during the TUNEL test, to re-
move the 3′-phostate ends and so unmask cleaved DNA bearing 3′P
ends. In these conditions, we found a positive TUNEL signal (Fig. 3A).
We further studied the putative activation of LEI/L-DNase II pathway.
Immunocytochemistry using an anti-LEI/L-DNase II showed a cytoplas-
mic localization in control cells whereas a nuclear localization was
detected in treated cells indicating the activation of the LEI/L-DNase II
pathway (Fig. 3B upper panel). A cytoplasmic-nuclear fractionation of
the cells analyzed by Western Blot shows the presence of L-DNase II
in nuclear fraction of ciproﬂoxacin-treated cells that further supports
the activation of this pathway (Fig. 3B lower panel). These results indicat-
ed that this model could be interesting to our investigation. Apoptosis In-
ducing Factor (AIF), another effector of caspase-independent cell death,
seemed also activated but in a reduced number of cells (Supplementary
Fig. 2).
3.3. Calpain inhibition protects cells from death
Since ciproﬂoxacin treatment causes lysosomal permeabilization
and cell death and because calpain inhibition rescues lysosomal per-
meabilization, we investigated the effect of calpain inhibition on cell
death.
The clonogenic assay performed in HeLa cells treated with cipro-
ﬂoxacin for 24 h showed a low survival. However, ciproﬂoxacin plus
calpain inhibitor VI signiﬁcantly protects cells from death, when
compared with control cells incubated only with calpain inhibitor
VI (Fig. 3C). These results indicate that calpain also protects cells from
death and that the lysosomal permeabilization is involved in this celldeath. Of note, the incubation of cells with calpain inhibitor alone in-
duces a decrease of cell viability per se. This is not a surprising effect
since calpains are involved in many physiological processes [17–19].
3.4. Lamp 2, a target of calpain 1
Given that calpain 1 seems to be responsible for lysosomal perme-
abilization, we were interested in identifying the calpain 1 target in
lysosomal membrane. A recent paper of Sahara and Yamashima sug-
gests that Hsp70.1 might be the target of calpains and shows that
under oxidative stress conditions, Hsp70.1 is degraded by this enzyme.
In our hands no degradation was found in vitro but, most important, in
our apoptosis paradigm no degradation of Hsp70.1 was seen (Fig. 4A).
To identify the calpain target which is involved in lysosomal perme-
abilization, LAMP 2 appeared as good candidate. Indeed, among the dif-
ferent proteins of the lysosomal membrane, LAMP 2 is highly expressed
and it is essential in many lysosomal functions. Western Blot analysis of
lysosomalmembrane protein revealed that LAMP2wasdegradedwhen
cells were treated with ciproﬂoxacin and that calpain inhibitor VI
inhibited LAMP 2 degradation as shown in Fig. 4B. To test further if
LAMP 2 degradation is responsible for lysosomal permeabilization,
wild typeMEF cells andMEF deleted in Lamp 2were treatedwith cipro-
ﬂoxacin alone or in combination with calpain inhibitor VI. Immuno-
staining showed that ciproﬂoxacin treated wild type cells underwent
lysosomal permeabilization as revealed by cathepsin D release to the
cytosol. By contrast, treatment with ciproﬂoxacin and calpain inhibitor
did not promote lysosomal permeabilization (Fig. 4C and Supplementa-
ry Fig. 3 upper panels), indicating that wild type MEF displayed the
same type of response as HeLa cells. The same was performed with
MEF−/− Lamp 2 cells indicated that ciproﬂoxacin could not promote
lysosomal permeabilization, at least not enough to allow cathepsinD re-
lease (Fig. 4C and Supplementary Fig. 3 middle panels). To further sup-
port these results, MEF Lamp 2−/− were transfected with a hLamp 2A
plasmid in order to restore LAMP 2 expression. Immunostaining of
these cells showed that transfected cells treated with ciproﬂoxacin re-
lease cathepsin D to the cytosol and that inhibition with calpain inhibi-
tor VI protects lysosomes from permeabilization, as in wild type cells
(Fig. 4C and Supplementary Fig. 3 lower panels). In addition, the release
of cathepsin D from the lysosomes is followed, in each case, by the
Fig. 3. Ciproﬂoxacin induces caspase independent cell death and activates LEI/L-DNase II. Panel A: TUNEL analysis: control and ciproﬂoxacin treated cells were TUNEL negative
(Control, Cipro). Incubating the cells with DNase I prior to the TUNEL labeling (DNase I) was used as a positive control. Ciproﬂoxacin treated cells became TUNEL positive after a
dephosphorylation step with alkaline phosphatase (AP) prior to TUNEL labeling (Cipro + AP). Scale bar represents 25 μm. Panel B: LEI/L-DNase II activation. Upper panel: immu-
nocytochemistry using an anti-LEI/L-DNase II shows a cytoplasmic localization in control cells and a nuclear localization in treated cells indicating the activation of the LEI/L-DNase
II. Scale bar represents 25 μm. Lower panel: Nuclear and cytoplasmic fractions from HeLa cells treated with ciproﬂoxacin (Cipro) or let untreated (Control) were analyzed by West-
ern Blot using anti-LEI/L-DNase II. A cytoplasmic localization of LEI in both control and ciproﬂoxacin treated cells was seen. Only nuclear fraction of ciproﬂoxacin treated cells
showed L-DNase II labeling. Actin was used as a loading control for cytoplasmic fraction and Lamin B for nuclear fraction. These are representative images of three independent
experiments. Panel C: Protection from ciproﬂoxacin-induced cell death by calpain inhibitor VI (clonogenic test): The clonogenic test showed a signiﬁcant survival increase in
HeLa cells treated with ciproﬂoxacin in combination with calpain inhibitor when compared with ciproﬂoxacin treatment alone. Results are expressed as the mean ± SD. All mea-
surements are different as calculated by a one way ANOVA test p b 0.05.
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that cleavage of LAMP 2A is a necessary and sufﬁcient condition to
permeabilize lysosomes. In turn, lysosomal permeabilization is neces-
sary to activate L-DNase II. Inhibition of calpain impairs both lysosomal
permeabilization and L-DNase II activation.
3.5. LAMP 2 is degraded in retina during LIRD
The cellular model that we used presents the same cell death effec-
tors as those seen in LIRD. In addition,we found that calpain 1 is respon-
sible of lysosomal permeabilization by targeting LAMP 2. Therefore, we
investigated if in vivo, during LIRD, LAMP 2 was degraded. To do this,
Fisher rats were exposed to continuous light for 5 or 7 days. After sacri-
ﬁce the rat retina proteinswere extracted forWestern Blot analysis.Wefound that ﬁve and seven days of retina illumination yields a similar
pattern of LAMP 2 degradation (Fig. 6).
4. Discussion
In this study we revealed a new substrate of calpain 1 at the lyso-
somal membrane level: LAMP 2A. Indeed, we found that calpain 1
promotes lysosomal permeabilization by targeting LAMP 2A in a cellu-
lar model (ciproﬂoxacin treated HeLa cells) in which the same cell
death pathway as the one seen in a LIRD model is activated. Moreover,
we also showed that, in this model, both in vitro and in vivo LAMP 2 is
degraded.
More in detail, we assessed if puriﬁed lysosomes from rat brain
were permeabilized by calpain 1 and calpain 2. Western Blot analysis
Fig. 4. Calpain 1 promotes lysosomal permeabilization by targeting LAMP 2. Panel A: left side represents an anti-Hsp70.1 Western Blot (WB) of HeLa cells treated with ciproﬂoxacin
or left untreated. Right side represents a total extract of HeLa cells digested with calpain 1, calpain 2 or treated with the calpain inhibitor, calpastatin. No cleavage of Hsp70 was
found, either in ciproﬂoxacin treated cells, or in cellular extracts in vitro. Actin was used as a loading control. These are representative images of three independent experiments.
Panel B: LAMP 2 Western Blot of HeLa cells left untreated (control), treated with ciproﬂoxacin (Cipro) or with ciproﬂoxacin and calpain inhibitor VI (Cipro + Cal inh VI). LAMP 2
was degraded in ciproﬂoxacin treated condition and recovered in the presence of calpain inhibitor VI. Ponceau red staining of the membrane and was used as a loading control.
These are representative images of three independent experiments. Panel C: Wild type MEF cells (+/+), LAMP 2 Knock Out cells (−/−) or LAMP 2 Knock Out cells transfected
with a hLamp 2A plasmid were left untreated (Control), treated with ciproﬂoxacin (Cipro) of with ciproﬂoxacin plus calpain inhibitor VI (Cipro + Cal inh VI) and immunostained
with anti Cathepsin D (red). Nuclei were stained with DAPI (blue). All control and calpain inhibitor treated cells showed a punctate staining, while in cells treated with ciproﬂoxacin
the staining was diffuse in wild type and LAMP 2A restored cells but remained punctate in lamp 2 KO cells. Scale bar represents 25 μm.
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tains an important amount of cathepsin D. It is worth noting that
basal levels of cathepsin D are seen in supernatants from control lyso-
somes and from lysosomes digested with calpain 2.
Because our studies indicated that lysosomal permeabilization is
promoted by calpain 1, at least, in in vitro conditions, we seek for a
model of lysosomal permeabilization under physiopathological condi-
tions in which cell death pathways, similar to the one seen in our LIRD
model, is activated. The rational for this was that an in vitro model will
allow for direct assessment of the underlying molecular mechanisms.We choose Boya's model and conﬁrmed that treatment of HeLa cells
with ciproﬂoxacin induces lysosomal permeabilization and cathepsin D
release, and that this cell death is caspase independent, in agreement
with previous studies (16). We also showed the activation of L-DNase II
and AIF, two molecules that are executers of caspase independent cell
death. Moreover, we found that calpain inhibition protects lysosomes
and prevent cathepsin D release. This was further conﬁrmed with the
use of a particular lysosome staining, LysoSensor which accumulates in
lysosomes and when it is excited by UV light the change of color is
observed as pH inside lysosomes changes. We assumed here that if
Fig. 5. Activation of LEI/L-DNase II is dependent of calpain activity on LAMP 2. Wild type MEF cells (+/+), LAMP 2 Knock Out cells (−/−) or LAMP 2 Knock Out cells transfected
with a hLamp 2A plasmid were left untreated (control), treated with ciproﬂoxacin (Cipro) of with ciproﬂoxacin plus calpain inhibitor VI (Cipro + Cal inh VI) and immunostained
with anti LEI/L-DNase II (red). Nuclei were stained with DAPI (blue). All control and calpain inhibitor treated cells showed a cytoplasmic staining, while in cells treated with cip-
roﬂoxacin the staining is nuclear in wild type and LAMP 2A restored cells. In lamp 2 KO cells ciproﬂoxacin treatment did not produce a nuclear translocation of L-DNase II. Scale bar
represents 10 μm.
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trafﬁcking of H+. Indeed LysoSensor shows a change in its wavelength
emission after treatmentwith ciproﬂoxacin. In the presence of calpain in-
hibitor VI, lysosome emission was similar to control cells. This result is
crucial because it shows that there is an authentic permeabilization of ly-
sosomes and not a lysosomal disruption.
The cellular model that we choose presents lysosomal perme-
abilization, cathepsin D release, caspase independent cell death, and
LEI/L-DNase II activation as in the LIRD model (15). We aimed to
identify the calpain 1 target. In 2010 Sahara proposed that calpain tar-
get during lysosomal permeabilization is the chaperon protein HSP 70.1.
We investigated HSP 70.1 degradation, by Western Blot in HeLa cells
treated with ciproﬂoxacin or total protein extract from HeLa cells
digested with calpain 1 or 2 and we could not observe HSP 70 cleavage
under these conditions, which are the same used to induce lysosomal
permeabilization in lysosomes from rat brain (Fig. 4 A). Among the pro-
teins of the lysosomalmembrane,we found that LAMP 2Awas degraded.
To study LAMP2 as target of calpain 1 during lysosomal permeabilization
we usedMEF cell in which LAMP 2was invalidated. MEF−/− Lamp 2 cells
did not undergo lysosomal permeabilization when treated with cipro-
ﬂoxacin but recover this property if the protein expression is restoredby a hLamp 2A plasmid, demonstrating that this protein is involved in ly-
sosomal permeabilization.Moreover, the activation of L-DNase II in these
cells is clearly dependent on cathepsin D release, calpain inhibition and
LAMP2A expression. Interestingly, in our LIRDmodel, the LAMP 2 degra-
dation was also found, suggesting that this might be the mechanism by
which cathepsin D is released from the lysosomes to allow L-DNase II
activation. Since inhibition of cathepsin D in our LIRD model partially
protects photoreceptors from cell death [15] and since calpain inhibition
protects cells fromdeathwhen treatedwith ciproﬂoxacin, itwould be in-
teresting to inhibit calpain in LIRDmodel and to study LAMP 2 state and
photoreceptors protection.
The mechanisms we described here are active in at least three very
different apoptosis paradigms in which caspases are not activated: the
LIRD, HeLa and MEF cells treated with ciproﬂoxacin, suggesting that it
is not just a particular situation but that these mechanisms can also op-
erate in other models where the activation of calpains is involved in
cell death. This is commonly seen in the central nervous system. For in-
stance trophic factor deprivation in sympathetic neurons induces calpain
1 cleavage of BAX. The proapoptotic fragment of BAX then pro-
motes cytochrome c release and apoptosis [20]. Relevantly, other
substrates of calpain 1 in neuronal cell death have been identiﬁed.
Fig. 6. LAMP 2 is cleaved during LIRD. Panel A: retinas from Fisher rats exposed to a
light/dark regular cycle (NI) or in continuous light environment for 5 to 7 days were
analyzed byWB using a LAMP 2 antibody. Fragments of LAMP 2 are seen in illuminated
retinas. Actin was used as a loading control. These are representative images of three
independent experiments. In total protein extract from wild type and Lamp 2 KO
MEF cells, anti-LAMP 2 antibody was used to reveal the position of LAMP 2 and the
non speciﬁc signal of this antibody. Panel B: The bands’ volume of LAMP 2 and actin
in the retina were quantiﬁed by using the Fiji image software. Graph represents the
ratio of LAMP 2 expression as compared with actin. Two bands have been quantiﬁed;
the full length and the cleaved species. Asterisks indicate values that are signiﬁcantly
different from the control (student’s test, p b 0.05).
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calpain 1 cleaves BID and BAX, the truncated pro-apoptotic forms of
these proteins are then relocalized to the mitochondria and induceFig. 7.Hypothetical site of LAMP 2 cleavage by calpain. Panel A: the three domains of LAMP 2
age site with the best score (position 209) predicted by the Multiple Kernel Learning (MKL
conditions calpain do not have access to luminal domain of LAMP 2 that contains the cleavag
a pore. We hypothesize that it is at this moment that calpain 1 may cleave LAMP 2A.apoptosis concomitantly, with the cleavage of anti-apoptotic protein
BCL-2 by calpain 1 [21]. It has been shown that AIF, amitochondrial pro-
tein, is also a calpain 1 substrate [22].Moreover, AIF has been largely im-
plicated in neuronal cell death during focal cerebral ischemia [23], after
traumatic brain injury [24], glutamate cytotoxicity [25] and models of
Alzheimer disease [26,27].
Calpain 1 substrates comprise a wide variety of proteins. Those
implicated in neuronal cell death are proapoptotic proteins in some
cases, but not only. Huntingtin has been also found as calpain 1 sub-
strate in a Huntington disease model [28]. In Alzheimer disease it
has been propose that conversion of p35 into p25 by calpain 1 pro-
longs the activation of cdk5 which in turns hyperphosphorylates the
protein tau inducing apoptosis of primary neurons [29]. Indeed, mech-
anisms of substrate recognition and cleavage by calpains are not well
known, making the task of identiﬁcation of calpain substrates very dif-
ﬁcult.We showhere that LAMP2A is a new calpain 1 substrate that par-
ticipates in neuronal cell death. In contrast to other calpain substrates
implicated in neuronal cell death, LAMP 2 is particular according to its
structure, i.e., it is a type 1 transmembrane protein.
It is very likely that LAMP 2A is not the sole calpain substrate dur-
ing lysosomal permeabilization. Lysosomal membrane proteins from
HeLa cells obtained under the three conditions (control, ciproﬂoxacin
and ciproﬂoxacin combinedwith calpain inhibitor VI) are actually being
analyzed by mass spectrometry in our laboratory. It is worth to note
that the study of membrane proteins in general represents a challenge
due to the hydrophobicity of this type of proteins.We expect to discover
additional calpain substrates in the lysosomal membrane and to study
their implication on lysosomal permeabilization and cell death.
The mechanism by which calpain 1 cleaves LAMP 2A is not eluci-
dated yet. LAMP 2 has three domains: luminal, transmembrane and
cytoplasmic (Fig. 7A). The Multiple Kernel Learning tool by DuVerle
(www.calpain.org) allowed us to predict the calpain cleavage site at
the luminal domain (Fig. 7B). Therefore, in normal conditions,
calpain 1 does not have access to the LAMP 2 luminal domain, How-
ever, when the Chaperon Mediated Autophagy (CMA) is activated,
LAMP 2A, oligomerizes and forms a pore that allows the transport
of speciﬁc proteins thought the lysosomal membrane [30]. We pro-
pose the hypothesis that calpain 1 cleaves LAMP 2A when it forms: Cytoplasmic, transmembrane and luminal. Panel B: the green bar represents the cleav-
) tool (DuVerle). Blue bars represent other possible sites. Panel C: under physiological
e site predicted by the MKL tool. However, during CMA LAMP 2A oligomerize and forms
2253G.E. Villalpando Rodriguez, A. Torriglia / Biochimica et Biophysica Acta 1833 (2013) 2244–2253the CMA pore (Fig. 7C). Further research should be done to verify
this hypothesis.
In summary, we showed the implication of calpain 1 in cell death
due to the lysosomal permeabilization caused by this protease Involving
LAMP 2A as a substrate.
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